Orbimed Advisors Llc bought $15.0M of Aspen Neuroscience (ASPE)
Executed Nov 2, disclosed Nov 4, 2 days later.
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
Orbimed Advisors Llc (Director) filed 18 Form 4 reports as a reporting entity in the trailing twelve months (10 purchases, 8 sales, 1 filed past the two-business-day deadline), most often in Sionna Therapeutics, Inc. (SION). Across 8 priced purchase filings, the average 21-session return was +11.7% from execution and +14.6% from disclosure (delay-adjusted; derived). The largest single filing was $38.9M of ELVN (858,646 sh across 3 lots, as filed), executed Jun 22.
Healthcare · Aspen Neuroscience, Inc. develops autologous induced pluripotent stem cell (iPSC)-derived cell replacement therapies for neurodegenerative…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→